Editor-in-Chief of the Canadian Medical Association Journal (CMAJ)
Con to the question "Should Performance Enhancing Drugs (Such as Steroids) Be Accepted in Sports?"
"Athletes are now competing on an Olympic stage. Some performances may be suspect and proven to be illegitimate. But the overwhelming majority of athletes will compete fairly and cleanly. Sadly, their accomplishments are sometimes overshadowed by the debased conduct of a minority. Athletes from Canada and from other countries are the product of sport systems that work tirelessly to address the doping scourge.
Antidoping programs in an Olympic setting ensure fair play
and maintain public trust. A concern for drug use in community sport is equally important; the implications of such behaviour compel thoughtful, strategic interventions to ensure sporting integrity and public health."
"Doping, Sport and the Community," Canadian Medical Association Journal (CMAJ), Aug. 12, 2008
Experts Individuals with MDs, JDs, PhDs, or equivalent advanced degrees in fields relevant to performance enhancing drugs and sports. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to performance enhancing drugs and sports.
Involvement and Affiliations:
Editor-in-Chief, Canadian Medical Association Journal (CMAJ), Jan. 2, 2007-present
Professor of Medicine, Surgery, Anesthesiology and Epidemiology, in the Department of Medicine (Critical Care), Department of Anesthesiology and Surgery, and Department of Epidemiology & Community Medicine, University of Ottawa
Senior Scientist, Clinical Epidemiology, Ottawa Health Research Institute (OHRI)
Critical Care Physician, Ottawa Hospital
Chair, Transfusion and Critical Research, Ottawa Health Research Institute, University of Ottawa
Vice-Chair of Research, Department of Medicine at the University of Ottawa, 2003-2007
Recipient, Premier's Research Excellence Award, Ontario Ministry of Health and Long-Term Care, 2002
Recipient, Researcher of the Year Award, OHRI, 2001
Established the University of Ottawa Centre for Transfusion Research, 1999
Established the Clinical Epidemiology Program at the General Campus of the Ottawa Hospital, 1998
Fellow, Royal College of Physicians and Surgeons of Canada (FRCPC)
MD, University of Ottawa, 1986
MHSc (Master of Health Sciences), Epidemiology, University of British Columbia, 1993
Cowritten with Andrew Pipe, MD, "Doping, Sport and the Community," CMAJ, Aug. 12, 2008
Cowritten with S. Kanji, R. Stewart, D. Fergusson, L. McIntyre, and A. Turgeon, "Treatment of New-Onset Atrial Fibrillation in Non-Cardiac ICU Patients: A Systematic Review of Randomized Controlled Trials," Critical Care Medicine, May 2008
Cowritten with H. Clavet, D. Fergusson, S. Doucette, and G. Trudel, "Joint Contracture Following Prolonged Stay in the Intensive Care Unit," CMAJ, Mar. 11, 2008
Cowritten with James A. Russell, MD, et al., "Vasopressin Versus Norepinephrine Infusion in Patients with Septic Shock," New England Journal of Medicine, Feb. 28, 2008
Cowritten with Morris A. Blajchman, MD, et al., "A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care," New England Journal of Medicine, Feb. 11, 1999
Primary area of research expertise is transfusion therapy, for which he has been published in the New England Journal of Medicine and the Journal of the American Medical Association